Lx9211.1-204-Dpn
Research payments
$8,763,177
Through program year 2025, $8,763,177 in research payments was reported against Lx9211.1-204-Dpn, across 1,325 payments, paid by Lexicon Pharmaceuticals, Inc..
- Paid by
- Lexicon Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,618,592 | 861 |
| 2024 | Research | $3,144,585 | 464 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Marina Raikhel Lomita, CA Named on 51 payments
- Albert Jarvi Salt Lake City, UT Named on 44 payments
- Ahmet Dirican New Bedford, MA Named on 41 payments
- Leon Barkodar West Hills, CA Named on 37 payments
- John Beckes National City, CA Named on 36 payments
- Jeffrey Wayne Lincoln, CA Named on 28 payments
- Manjoo Sharma Hempstead, NY Named on 28 payments
- Soheil Hekmat Inglewood, CA Named on 25 payments
- Anand Patel Jacksonville, FL Named on 25 payments
- Robinson Koilpillai Winter Haven, FL Named on 24 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.